Clinical Surveillance Tool to Screen for Unmet Palliative Needs Among Patients in the Final Year of Life
Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Nov 20, 2019
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Recently, van Walraven et al described the Hospital One-year Mortality Risk (HOMR) score for predicting 1-year mortality for patients admitted to hospital. HOMR is based on 12 administrative data points routinely coded by hospitals at the time of discharge and available in the CIHI Discharge Abstract Database. The model has been externally validated with excellent discrimination and calibration. Among HOMR's 12 data fields, nine are routinely available in the Electronic Health Record (EHR) at the time of admission in Ontario. Using a method similar to that used to derive HOMR, the investiga...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All newly admitted patients to selected medical units in participating sites during the 6-9-month intervention implementation period
- • \[To be assessed for unmet palliative needs\] the patient must be competent and have the ability to participate in assessments (i.e. answer assessment questions and understand and speak sufficient English to participate).
- Exclusion Criteria:
- • N/A for mHOMR/HOMR-Now! intervention
- • For palliative needs assessments: incapability of completing the ESAS and 4-Item ACP tools, either because of capacity/cognitive impairment or English-language ability.
About Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Ontario, Canada
London, Ontario, Canada
Ottawa, Ontario, Canada
Cambridge, Ontario, Canada
Toronto, Ontario, Canada
Kingston, Ontario, Canada
Toronto, Ontario, Canada
Toronto, Ontario, Canada
Brampton, Ontario, Canada
Orangeville, Ontario, Canada
Ottawa, Ontario, Canada
Ottawa, Ontario, Canada
Pembroke, Ontario, Canada
Windsor, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials